Image pharmaphorum Editor R&D Company profile: IDEA Pharma We are in the most competitive period ever for the pharmaceutical industry, characterised by incremental innovation and looming patent cliffs – and path-to-market strategy firm IDEA Pharma R&D Innovating in clinical trial recruitment Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients on time. Sales & Marketing Sponsored Good data supports pharma sales reps to drive lead generatio... Allow pharma sales reps to focus on the job in hand by making sure they have access to up-to-date, clean, accurate data. Debates & Insight Ensuring delivery of healthcare professional education Pharma companies always need to know they can get the right information to the right people at the right time. Load more results
R&D Company profile: IDEA Pharma We are in the most competitive period ever for the pharmaceutical industry, characterised by incremental innovation and looming patent cliffs – and path-to-market strategy firm IDEA Pharma
R&D Innovating in clinical trial recruitment Clinical trial recruitment is in crisis, with 80% of trials failing to recruit the required number of patients on time.
Sales & Marketing Sponsored Good data supports pharma sales reps to drive lead generatio... Allow pharma sales reps to focus on the job in hand by making sure they have access to up-to-date, clean, accurate data.
Debates & Insight Ensuring delivery of healthcare professional education Pharma companies always need to know they can get the right information to the right people at the right time.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
